Ocular Toxicity From New Oncology Agents: Safety Review
Wider use of targeted cancer drugs and immunotherapies is elevating ocular toxicity risk, requiring early recognition, multidisciplinary coordination, and proactive monitoring to protect vision without compromising cancer control.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.